Shanghai Shyndec Pharmaceutical Co., Ltd. (SHA:600420)
China flag China · Delayed Price · Currency is CNY
9.15
-0.05 (-0.54%)
May 20, 2026, 11:30 AM CST

SHA:600420 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
8,6769,21810,77011,78712,81013,756
Other Revenue
145.01145.01167.77282.98149.79189.06
8,8219,36310,93812,07012,95913,945
Revenue Growth (YoY)
-15.36%-14.39%-9.38%-6.86%-7.07%11.06%
Cost of Revenue
6,2396,4386,8227,5388,0917,909
Gross Profit
2,5822,9254,1164,5324,8686,036
Selling, General & Admin
1,2061,2801,9212,9063,4144,220
Research & Development
405.67437.58565.65562.24517.14584.97
Other Operating Expenses
83.178.1278.8899113.17128.31
Operating Expenses
1,7071,8122,5633,5494,0274,958
Operating Income
874.531,1141,553983.4841.241,078
Interest Expense
-3.52-4.39-36.89-57.88-107.31-110.47
Interest & Investment Income
177.04177.49151.08136.4861.6948.84
Currency Exchange Gain (Loss)
2.292.2940.6128.4498.32-32.65
Other Non Operating Income (Expenses)
-23.92-2.31-2.01-4.09-4.23-5.75
EBT Excluding Unusual Items
1,0261,2871,7051,086889.71978
Impairment of Goodwill
------132.15
Gain (Loss) on Sale of Investments
------24.04
Gain (Loss) on Sale of Assets
-2.41-2.65-31.31-31.85-1.10.2
Asset Writedown
-24.44-32.79-28.26-13.13-4.93-10.81
Other Unusual Items
65.2976.1927.3355.19100.45107
Pretax Income
1,0651,3281,6731,097984.12918.21
Income Tax Expense
154.09185.42340.97131.95116.6397.06
Earnings From Continuing Operations
910.771,1421,332964.61867.48821.15
Minority Interest in Earnings
-192.18-200.56-248.46-272.73-239.69-252.87
Net Income
718.59941.61,084691.88627.79568.28
Net Income to Common
718.59941.61,084691.88627.79568.28
Net Income Growth
-35.48%-13.11%56.62%10.21%10.47%-12.41%
Shares Outstanding (Basic)
1,3411,3411,3411,2731,0271,027
Shares Outstanding (Diluted)
1,3411,3411,3411,2731,1561,178
Shares Change (YoY)
0.00%-5.31%10.13%-1.82%-0.14%
EPS (Basic)
0.540.700.810.540.610.55
EPS (Diluted)
0.540.700.810.540.540.48
EPS Growth
-35.48%-13.11%48.72%0.07%12.52%-12.29%
Free Cash Flow
762.351,4342,0361,3632,5481,158
Free Cash Flow Per Share
0.571.071.521.072.200.98
Dividend Per Share
0.3000.3000.3000.1000.1000.100
Dividend Growth
--200.00%---
Gross Margin
29.27%31.25%37.63%37.55%37.57%43.28%
Operating Margin
9.92%11.89%14.19%8.15%6.49%7.73%
Profit Margin
8.15%10.06%9.91%5.73%4.84%4.08%
Free Cash Flow Margin
8.64%15.32%18.62%11.29%19.66%8.31%
EBITDA
1,5551,8122,3251,8021,6711,857
EBITDA Margin
17.63%19.36%21.25%14.93%12.90%13.31%
D&A For EBITDA
680.16698.59772.32818.89830.01778.52
EBIT
874.531,1141,553983.4841.241,078
EBIT Margin
9.92%11.89%14.19%8.15%6.49%7.73%
Effective Tax Rate
14.47%13.97%20.38%12.03%11.85%10.57%
Revenue as Reported
8,8219,36310,93812,07012,95913,945
Advertising Expenses
-4.696.184.643.297.1
Source: S&P Global Market Intelligence. Standard template. Financial Sources.